Effects of resveratrol supplementation on serum concentrations of plasminogen activator inhibitor-1, fibroblast growth factor 21, and adiponectin in patients with nonalcoholic fatty liver disease

Authors

Institutions

Publication Details

Journal
BMC Nutrition
Published
2025-02-10
DOI
https://doi.org/10.1186/s40795-025-00997-4
Citations
1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.35

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of resveratrol supplementation on serum concentrations of plasminogen activator inhibitor-1, fibroblast growth factor 21, and adiponectin in patients with nonalcoholic fatty liver disease

Laleh Farzin, Elahe Mansouri, Somayyeh Asghari, Farshad Amirkhizi et al.
1 citations
BMC Nutrition
Liver Disease Diagnosis and Treatment
1.35
article

Effects of resveratrol supplementation on serum concentrations of plasminogen activator inhibitor-1, fibroblast growth factor 21, and adiponectin in patients with nonalcoholic fatty liver disease

Laleh Farzin, Elahe Mansouri, Somayyeh Asghari, Farshad Amirkhizi, Emma Baker, Shiva Salehi
article en
1 citations

Abstract

No abstract available for this paper.
BMC NutritionVol. 11(1)
Tabriz University of Medical Sciences (IR), Zabol University of Medical Sciences (IR), Cabrini Hospital (AU), Tehran University of Medical Sciences (IR)
Tabriz University of Medical Sciences, University of Tabriz
Zero hunger
Openalex Percentile: Top 23%
Liver Disease Diagnosis and Treatment
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.